| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 556.30M | 542.50M | 463.40M | 364.40M | 285.10M | 451.50M |
| Gross Profit | 194.30M | 193.80M | 114.70M | 67.40M | 29.90M | 111.80M |
| EBITDA | 86.60M | 127.00M | 108.90M | 70.30M | 43.20M | 123.40M |
| Net Income | 42.90M | 47.80M | 44.20M | 8.10M | -13.60M | 51.60M |
Balance Sheet | ||||||
| Total Assets | 639.30M | 615.60M | 537.20M | 536.00M | 532.50M | 568.80M |
| Cash, Cash Equivalents and Short-Term Investments | 20.30M | 16.50M | 11.70M | 38.30M | 12.50M | 5.50M |
| Total Debt | 219.20M | 184.40M | 172.70M | 230.30M | 263.70M | 293.40M |
| Total Liabilities | 300.10M | 268.70M | 269.00M | 316.40M | 326.00M | 347.30M |
| Stockholders Equity | 339.20M | 346.90M | 268.20M | 219.60M | 206.50M | 221.50M |
Cash Flow | ||||||
| Free Cash Flow | 92.50M | 70.50M | 73.70M | 91.60M | 57.70M | 87.70M |
| Operating Cash Flow | 104.00M | 88.90M | 91.90M | 98.50M | 65.20M | 102.20M |
| Investing Cash Flow | -41.30M | -40.50M | -18.20M | -6.90M | -7.00M | -14.10M |
| Financing Cash Flow | -66.40M | -42.90M | -102.10M | -65.80M | -47.70M | -89.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £218.94M | 16.03 | 12.51% | 7.08% | 6.18% | 4.22% | |
65 Neutral | £1.63B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £26.88M | -1.20 | 63.25% | ― | -1.96% | 28.69% | |
56 Neutral | £647.99M | 8.84 | -113.93% | 1.40% | 3.94% | ― | |
52 Neutral | £49.07M | -3.03 | -43.73% | ― | -38.64% | -792.57% | |
46 Neutral | £731.17M | -2.16 | -62.07% | 4.48% | -19.03% | -318.35% |